{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:49:35Z","timestamp":1792158575085,"version":"4.4.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32470786"],"award-info":[{"award-number":["32470786"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018625","name":"Science and Technology Innovation Plan Of Shanghai Science and Technology Commission","doi-asserted-by":"publisher","award":["23Y11903600"],"award-info":[{"award-number":["23Y11903600"]}],"id":[{"id":"10.13039\/501100018625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018558","name":"Shanghai Shuguang Program","doi-asserted-by":"publisher","award":["22SG36"],"award-info":[{"award-number":["22SG36"]}],"id":[{"id":"10.13039\/501100018558","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-026-04468-3","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T13:56:32Z","timestamp":1784642192000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical association between myelodysplastic syndrome and de novo bone metastasis in urothelial carcinoma"],"prefix":"10.1186","volume":"24","author":[{"given":"Zhilong Zestel","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengru","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianru","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9931-8371","authenticated-orcid":false,"given":"Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"4468_CR1","unstructured":"Bladder Cancer Treatment. Patient Version. PDQ Cancer Information Summaries. Bethesda (MD); 2002."},{"key":"4468_CR2","doi-asserted-by":"crossref","unstructured":"Saginala K, Barsouk A, Aluru JS, Rawla P, Padala SA, Barsouk A. Epidemiology of Bladder Cancer. Med Sci (Basel). 2020;8(1).","DOI":"10.3390\/medsci8010015"},{"issue":"2","key":"4468_CR3","doi-asserted-by":"publisher","first-page":"e483","DOI":"10.1016\/j.clgc.2017.10.012","volume":"16","author":"A Necchi","year":"2018","unstructured":"Necchi A, Pond GR, Pal SK, Agarwal N, Bowles DW, Plimack ER, Yu EY, Ladoire S, Baniel J, Crabb S, et al. Bone Metastases as the Only Metastatic Site in Patients With Urothelial Carcinoma: Focus on a Special Patient Population. Clin Genitourin Cancer. 2018;16(2):e483\u201390.","journal-title":"Clin Genitourin Cancer"},{"issue":"1","key":"4468_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.euf.2019.06.007","volume":"6","author":"SH Patel","year":"2020","unstructured":"Patel SH, Panian J, Bree K, Derweesh I, Millard F, Randall J, McKay R. Systemic Treatment of Bone Disease in Metastatic Urinary Malignancies. Eur Urol Focus. 2020;6(1):17\u201325.","journal-title":"Eur Urol Focus"},{"issue":"9","key":"4468_CR5","doi-asserted-by":"publisher","first-page":"e016022","DOI":"10.1136\/bmjopen-2017-016022","volume":"7","author":"E Svensson","year":"2017","unstructured":"Svensson E, Christiansen CF, Ulrichsen SP, R\u00f8rth MR, S\u00f8rensen HT. Survival after bone metastasis by primary cancer type: a Danish population-based cohort study. BMJ Open. 2017;7(9):e016022.","journal-title":"BMJ Open"},{"issue":"16","key":"4468_CR6","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1056\/NEJMra030831","volume":"350","author":"GD Roodman","year":"2004","unstructured":"Roodman GD. Mechanisms of bone metastasis. N Engl J Med. 2004;350(16):1655\u201364.","journal-title":"N Engl J Med"},{"key":"4468_CR7","doi-asserted-by":"publisher","first-page":"855188","DOI":"10.3389\/fonc.2022.855188","volume":"12","author":"BM Foster","year":"2022","unstructured":"Foster BM, Shi L, Harris KS, Patel C, Surratt VE, Langsten KL, Kerr BA. Bone Marrow-Derived Stem Cell Factor Regulates Prostate Cancer-Induced Shifts in Pre-Metastatic Niche Composition. Front Oncol. 2022;12:855188.","journal-title":"Front Oncol"},{"issue":"5","key":"4468_CR8","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nrc.2017.6","volume":"17","author":"H Peinado","year":"2017","unstructured":"Peinado H, Zhang H, Matei IR, Costa-Silva B, Hoshino A, Rodrigues G, Psaila B, Kaplan RN, Bromberg JF, Kang Y, et al. Pre-metastatic niches: organ-specific homes for metastases. Nat Rev Cancer. 2017;17(5):302\u201317.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"4468_CR9","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1186\/s12957-023-03220-5","volume":"21","author":"C Gawlik","year":"2023","unstructured":"Gawlik C, Lane J, Horattas M. Tumor-to-tumor spread: a case report and literature review of renal cell carcinoma metastasis into thyroid cancer. World J Surg Oncol. 2023;21(1):362.","journal-title":"World J Surg Oncol"},{"issue":"2","key":"4468_CR10","doi-asserted-by":"publisher","first-page":"CNS09","DOI":"10.2217\/cns-2017-0022","volume":"7","author":"JT Pham","year":"2018","unstructured":"Pham JT, Kim RC, Nguyen A, Bota D, Kong XT, Vadera S, Hsu F, Carrillo JA. Intracranial meningioma with carcinoma tumor-to-tumor metastasis: two case reports. CNS Oncol. 2018;7(2):CNS09.","journal-title":"CNS Oncol"},{"issue":"3","key":"4468_CR11","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1152\/physrev.00012.2019","volume":"101","author":"P Clezardin","year":"2021","unstructured":"Clezardin P, Coleman R, Puppo M, Ottewell P, Bonnelye E, Paycha F, Confavreux CB, Holen I. Bone metastasis: mechanisms, therapies, and biomarkers. Physiol Rev. 2021;101(3):797\u2013855.","journal-title":"Physiol Rev"},{"issue":"4","key":"4468_CR12","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/leu.2017.7","volume":"31","author":"H Weidner","year":"2017","unstructured":"Weidner H, Rauner M, Trautmann F, Schmitt J, Balaian E, Mies A, Helas S, Baschant U, Khandanpour C, Bornh\u00e4user M, et al. Myelodysplastic syndromes and bone loss in mice and men. Leukemia. 2017;31(4):1003\u20137.","journal-title":"Leukemia"},{"issue":"7290","key":"4468_CR13","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/nature08851","volume":"464","author":"MH Raaijmakers","year":"2010","unstructured":"Raaijmakers MH, Mukherjee S, Guo S, Zhang S, Kobayashi T, Schoonmaker JA, Ebert BL, Al-Shahrour F, Hasserjian RP, Scadden EO, et al. Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia. Nature. 2010;464(7290):852\u20137.","journal-title":"Nature"},{"key":"4468_CR14","doi-asserted-by":"publisher","first-page":"101071","DOI":"10.1016\/j.jbior.2024.101071","volume":"95","author":"E Ceneri","year":"2025","unstructured":"Ceneri E, De Stefano A, Casalin I, Finelli C, Curti A, Paolini S, Parisi S, Ardizzoia F, Cristiano G, Boultwood J, et al. Signaling pathways and bone marrow microenvironment in myelodysplastic neoplasms. Adv Biol Regul. 2025;95:101071.","journal-title":"Adv Biol Regul"},{"key":"4468_CR15","doi-asserted-by":"publisher","first-page":"1238331","DOI":"10.3389\/fonc.2023.1238331","volume":"13","author":"S Liu","year":"2023","unstructured":"Liu S, Li H, Dong Y, Zhang D. Case Report: Tumor-to-tumor metastasis with prostate cancer metastatic to lung cancer: the first reported case. Front Oncol. 2023;13:1238331.","journal-title":"Front Oncol"},{"key":"4468_CR16","doi-asserted-by":"crossref","unstructured":"Pepe L, Fiorentino V, Pizzimenti C, Riganati G, Franchina M, Micali M, Russotto F, Ieni A, Tuccari G, Fadda G et al. The Simultaneous Use of Bladder Epicheck((R)) and Urinary Cytology Can Improve the Sensitivity and Specificity of Diagnostic Follow-Up of Urothelial Lesions: Up-to-Date Data from a Multi-Institutional Cohort. Diseases. 2024;12(9).","DOI":"10.3390\/diseases12090219"},{"key":"4468_CR17","doi-asserted-by":"crossref","unstructured":"Germana E, Pepe L, Pizzimenti C, Ballato M, Pierconti F, Tuccari G, Ieni A, Giuffre G, Fadda G, Fiorentino V et al. Programmed Cell Death Ligand 1 (PD-L1) Immunohistochemical Expression in Advanced Urothelial Bladder Carcinoma: An Updated Review with Clinical and Pathological Implications. Int J Mol Sci. 2024;25(12).","DOI":"10.3390\/ijms25126750"},{"issue":"3","key":"4468_CR18","doi-asserted-by":"publisher","first-page":"101989","DOI":"10.1016\/j.xcrm.2025.101989","volume":"6","author":"MM Buttigieg","year":"2025","unstructured":"Buttigieg MM, Vlasschaert C, Bick AG, Vanner RJ, Rauh MJ. Inflammatory reprogramming of the solid tumor microenvironment by infiltrating clonal hematopoiesis is associated with adverse outcomes. Cell Rep Med. 2025;6(3):101989.","journal-title":"Cell Rep Med"},{"issue":"12","key":"4468_CR19","doi-asserted-by":"publisher","first-page":"3162","DOI":"10.3324\/haematol.2020.264143","volume":"106","author":"M Schino","year":"2021","unstructured":"Schino M, Fiorentino V, Rossi E, Betti S, Di Cecca M, Ranucci V, Chiusolo P, Martini M, De Stefano V, Larocca LM. Bone marrow megakaryocytic activation predicts fibrotic evolution of Philadelphia-negative myeloproliferative neoplasms. Haematologica. 2021;106(12):3162\u20139.","journal-title":"Haematologica"},{"issue":"1","key":"4468_CR20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ydbio.2009.10.004","volume":"337","author":"CL Fisher","year":"2010","unstructured":"Fisher CL, Lee I, Bloyer S, Bozza S, Chevalier J, Dahl A, Bodner C, Helgason CD, Hess JL, Humphries RK, et al. Additional sex combs-like 1 belongs to the enhancer of trithorax and polycomb group and genetically interacts with Cbx2 in mice. Dev Biol. 2010;337(1):9\u201315.","journal-title":"Dev Biol"},{"issue":"2","key":"4468_CR21","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/leu.2013.336","volume":"28","author":"T Haferlach","year":"2014","unstructured":"Haferlach T, Nagata Y, Grossmann V, Okuno Y, Bacher U, Nagae G, Schnittger S, Sanada M, Kon A, Alpermann T, et al. Landscape of genetic lesions in 944 patients with myelodysplastic syndromes. Leukemia. 2014;28(2):241\u20137.","journal-title":"Leukemia"},{"issue":"9","key":"4468_CR22","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1038\/s41379-022-01074-y","volume":"35","author":"A Sakhdari","year":"2022","unstructured":"Sakhdari A, Class C, Montalban-Bravo G, Sasaki K, Bueso-Ramos CE, Patel KP, Routbort MJ, Loghavi S, Ok CY, Quesada A, et al. Immunohistochemical loss of enhancer of Zeste Homolog 2 (EZH2) protein expression correlates with EZH2 alterations and portends a worse outcome in myelodysplastic syndromes. Mod Pathol. 2022;35(9):1212\u20139.","journal-title":"Mod Pathol"},{"issue":"40","key":"4468_CR23","doi-asserted-by":"publisher","first-page":"eabo8043","DOI":"10.1126\/sciadv.abo8043","volume":"8","author":"A Piunti","year":"2022","unstructured":"Piunti A, Meghani K, Yu Y, Robertson AG, Podojil JR, McLaughlin KA, You Z, Fantini D, Chiang M, Luo Y, et al. Immune activation is essential for the antitumor activity of EZH2 inhibition in urothelial carcinoma. Sci Adv. 2022;8(40):eabo8043.","journal-title":"Sci Adv"},{"key":"4468_CR24","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1200\/JCO.2023.41.6_suppl.506","volume":"41","author":"M Hussain","year":"2023","unstructured":"Hussain M, Kocherginsky M, Singh P, et al. A pilot study of tazemetostat and pembrolizumab in advanced urothelial carcinoma (ETCTN 10183). J Clin Oncol. 2023;41:506\u2013506.","journal-title":"J Clin Oncol"},{"key":"4468_CR25","doi-asserted-by":"publisher","first-page":"117043","DOI":"10.1016\/j.bone.2024.117043","volume":"181","author":"P Dashti","year":"2024","unstructured":"Dashti P, Lewallen EA, Gordon JAR, Montecino MA, Davie JR, Stein GS, van Leeuwen J, van der Eerden BCJ, van Wijnen AJ. Epigenetic regulators controlling osteogenic lineage commitment and bone formation. Bone. 2024;181:117043.","journal-title":"Bone"},{"issue":"5","key":"4468_CR26","doi-asserted-by":"publisher","first-page":"760","DOI":"10.4161\/epi.28078","volume":"9","author":"I Ibragimova","year":"2014","unstructured":"Ibragimova I, Dulaimi E, Slifker MJ, Chen DY, Uzzo RG, Cairns P. A global profile of gene promoter methylation in treatment-na\u00efve urothelial cancer. Epigenetics. 2014;9(5):760\u201373.","journal-title":"Epigenetics"},{"issue":"6","key":"4468_CR27","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.ccr.2010.11.015","volume":"18","author":"ME Figueroa","year":"2010","unstructured":"Figueroa ME, Abdel-Wahab O, Lu C, Ward PS, Patel J, Shih A, Li Y, Bhagwat N, Vasanthakumar A, Fernandez HF, et al. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell. 2010;18(6):553\u201367.","journal-title":"Cancer Cell"},{"issue":"4","key":"4468_CR28","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/0092-8674(94)90221-6","volume":"77","author":"YJ Kim","year":"1994","unstructured":"Kim YJ, Bj\u00f6rklund S, Li Y, Sayre MH, Kornberg RD. A multiprotein mediator of transcriptional activation and its interaction with the C-terminal repeat domain of RNA polymerase II. Cell. 1994;77(4):599\u2013608.","journal-title":"Cell"},{"issue":"3","key":"4468_CR29","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.anndiagpath.2012.11.004","volume":"17","author":"H Wen","year":"2013","unstructured":"Wen H, Feng CC, Ding GX, Meng DL, Ding Q, Fang ZJ, Xia GW, Xu G, Jiang HW. Med19 promotes bone metastasis and invasiveness of bladder urothelial carcinoma via bone morphogenetic protein 2. Ann Diagn Pathol. 2013;17(3):259\u201364.","journal-title":"Ann Diagn Pathol"},{"issue":"4","key":"4468_CR30","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/nm.3512","volume":"20","author":"RN Suragani","year":"2014","unstructured":"Suragani RN, Cadena SM, Cawley SM, Sako D, Mitchell D, Li R, Davies MV, Alexander MJ, Devine M, Loveday KS, et al. Transforming growth factor-\u03b2 superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis. Nat Med. 2014;20(4):408\u201314.","journal-title":"Nat Med"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04468-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04468-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04468-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:02:33Z","timestamp":1792155753000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04468-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4468"],"URL":"https:\/\/doi.org\/10.1186\/s12957-026-04468-3","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"assertion":[{"value":"30 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The analysis of the anonymous data from the SEER database was exempted from medical ethics review and did not necessitate informed consent.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"400"}}